glp-1 drug names How medications are transforming diabetes and weight loss treatment GLP-1 Medications: What You Need
Description
Yerba mate does not directly increase glucagon-like peptide-1 (GLP-1) production in meaningful clinical amounts
Exenatide treatment did not change the eGFR significantly
GLP-1 Agonists in Type 1 DiabetesIndications and Use
According to the World Health Organization (WHO), over 422 million people globally live with diabetes, while obesity has nearly tripled since 1975, with more than 1 billion individuals affected, significantly increasing demand for effective GLP-1-based therapeutic interventions worldwide
RESEARCH presented at ACR Convergence 2025 highlights a potential new role for GLP-1 receptor agonists, medications widely used for type 2 diabetes and obesity, in the treatment of rheumatoid arthritis (RA)
